Panacea Biotec’s material subsidiary -- Panacea Biotec Pharma (PBPL) has made further investment of $9,25,000 (Rs 7.92 crore) in Panacea Biotec Inc., a wholly-owned subsidiary (WOS) company, as subscription for 9,25,00,000 shares of common stock of Panacea Biotec Inc. at a price of $0.01 per share.
The WOS has been set-up with an objective of establishing presence in the world’s largest healthcare market in US by pursuing comprehensive range of activities, including the buying, selling, marketing, importing, exporting, distributing, and dealing in services and products related to health and wellness, such as nutrition, dietary supplements, OTC drugs, medical devices, prescription drugs, and vaccines. The investment made by PBPL in WOS is to facilitate the capex and working capital requirements of PB Inc. and is in furtherance of its business. The business of the WOS is in line with the business activities of the company and PBPL.
Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1766.00 |
Dr. Reddys Lab | 1180.55 |
Cipla | 1510.65 |
Lupin | 2068.70 |
Zydus Lifesciences | 907.45 |
View more.. |